3.07
price up icon1.66%   0.05
after-market After Hours: 3.13 0.06 +1.95%
loading
Quantum Biopharma Ltd stock is traded at $3.07, with a volume of 207.87K. It is up +1.66% in the last 24 hours and up +23.79% over the past month. Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
See More
Previous Close:
$3.02
Open:
$2.97
24h Volume:
207.87K
Relative Volume:
0.71
Market Cap:
$17.90M
Revenue:
-
Net Income/Loss:
$-26.96M
P/E Ratio:
-0.3526
EPS:
-8.7061
Net Cash Flow:
$-8.25M
1W Performance:
-16.58%
1M Performance:
+23.79%
6M Performance:
-59.47%
1Y Performance:
-2.54%
1-Day Range:
Value
$2.97
$3.26
1-Week Range:
Value
$2.80
$3.76
52-Week Range:
Value
$2.07
$19.12

Quantum Biopharma Ltd Stock (QNTM) Company Profile

Name
Name
Quantum Biopharma Ltd
Name
Phone
-
Name
Address
-
Name
Employee
7
Name
Twitter
Name
Next Earnings Date
2026-03-27
Name
Latest SEC Filings
Name
QNTM's Discussions on Twitter

Compare QNTM vs VRTX, REGN, ARGX, ALNY, ONC

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
QNTM icon
QNTM
Quantum Biopharma Ltd
3.07 17.60M 0 -26.96M -8.25M -8.7061
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
441.70 113.01B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
753.93 79.87B 14.34B 4.50B 3.77B 41.56
ARGX icon
ARGX
Argen X Se Adr
840.87 51.51B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
333.39 45.29B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
319.94 34.41B 5.36B 287.73M 924.18M 2.5229

Quantum Biopharma Ltd Stock (QNTM) Latest News

pulisher
Apr 15, 2026

Quantum Biopharma buys additional $1 million of Bitcoin, other cryptocurrencies - MSN

Apr 15, 2026
pulisher
Apr 15, 2026

Quantum BioPharma announces private placement - MSN

Apr 15, 2026
pulisher
Apr 12, 2026

Press Releases about Royal Bank of Canada (Toronto Stock Exchange:RY) - FinancialContent

Apr 12, 2026
pulisher
Apr 10, 2026

Value Recap: Should I invest in Quantum BioPharma Ltd before earnings2026 News Drivers & Technical Buy Zone Confirmation - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 10, 2026

Operating expenses (excl. COGS) of Quantum Biopharma Ltd. Subordinate Voting Shares Class B – HAM:0K91 - TradingView — Track All Markets

Apr 10, 2026
pulisher
Apr 10, 2026

QNTM Should I Buy - Intellectia AI

Apr 10, 2026
pulisher
Apr 09, 2026

Whats the fair value of Quantum BioPharma Ltd stockWeekly Gains Report & Risk Managed Investment Entry Signals - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 08, 2026

Recap Report: Can Quantum BioPharma Ltd generate free cash flow2026 Historical Comparison & Stock Timing and Entry Methods - baoquankhu1.vn

Apr 08, 2026
pulisher
Apr 07, 2026

Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements - ACCESS Newswire

Apr 07, 2026
pulisher
Apr 04, 2026

Top Cannabis Stocks To Watch NowApril 4th - MarketBeat

Apr 04, 2026
pulisher
Apr 04, 2026

QNTM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Apr 04, 2026
pulisher
Apr 04, 2026

Quantum BioPharma Ltd. (QNTM) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 04, 2026
pulisher
Apr 04, 2026

Quantum BioPharma Ltd. (QNTM) stock price, news, quote and history - Yahoo Finance UK

Apr 04, 2026
pulisher
Apr 03, 2026

Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied - Sahm

Apr 03, 2026
pulisher
Apr 02, 2026

Quantum Biopharma Ltd. (QNTM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Apr 02, 2026
pulisher
Apr 02, 2026

Cannabis Stocks To Watch TodayApril 2nd - MarketBeat

Apr 02, 2026
pulisher
Apr 02, 2026

Quantum BioPharma Cleared to Proceed With $700 Million Market Manipulation Lawsuit After Motion to Dismiss Largely Denied - TipRanks

Apr 02, 2026
pulisher
Apr 02, 2026

[6-K] Quantum Biopharma Ltd. Current Report (Foreign Issuer) | QNTM SEC FilingForm 6-K - Stock Titan

Apr 02, 2026
pulisher
Apr 02, 2026

Quantum BioPharma submits IND application for MS drug candidate By Investing.com - Investing.com South Africa

Apr 02, 2026
pulisher
Apr 02, 2026

Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis - Sahm

Apr 02, 2026
pulisher
Apr 01, 2026

Quantum BioPharma (QNTM) Files FDA Application for New MS Drug - GuruFocus

Apr 01, 2026
pulisher
Apr 01, 2026

Promising Cannabis Stocks To Follow TodayApril 1st - MarketBeat

Apr 01, 2026
pulisher
Apr 01, 2026

Quantum BioPharma up 5% as Submits IND Application For Lucid-MS - marketscreener.com

Apr 01, 2026
pulisher
Apr 01, 2026

Quantum BioPharma Files FDA IND for Phase 2 Trial of Lucid-MS in Multiple Sclerosis - TipRanks

Apr 01, 2026
pulisher
Apr 01, 2026

Quantum BioPharma submits investigational new drug (IND) application to United States Food and Drug Administration (FDA) - marketscreener.com

Apr 01, 2026
pulisher
Apr 01, 2026

Quantum BioPharma submits IND application for MS drug candidate - Investing.com

Apr 01, 2026
pulisher
Apr 01, 2026

Quantum BioPharma (QNTM) advances Lucid-MS with FDA IND for Phase 2 MS trial - Stock Titan

Apr 01, 2026
pulisher
Mar 31, 2026

BioPharma Spoofing Suit Against Canadian Banks Proceeds - Law360

Mar 31, 2026
pulisher
Mar 31, 2026

Top Cannabis Stocks To Keep An Eye OnMarch 31st - MarketBeat

Mar 31, 2026
pulisher
Mar 31, 2026

Quantum BioPharma partners with Allucent for MS drug trial By Investing.com - Investing.com South Africa

Mar 31, 2026
pulisher
Mar 30, 2026

Quantum BioPharma (QNTM) Plans Phase 2 Trial for Multiple Sclero - GuruFocus

Mar 30, 2026
pulisher
Mar 30, 2026

Quantum BioPharma (QNTM) Partners with Allucent for Lucid-MS Pha - GuruFocus

Mar 30, 2026
pulisher
Mar 30, 2026

Quantum BioPharma (QNTM) Plans Phase 2 Trial for Multiple Sclerosis Treatment - GuruFocus

Mar 30, 2026
pulisher
Mar 30, 2026

Quantum BioPharma signs binding letter of intent with Allucent to conduct Phase 2 clinical trial in Multiple Sclerosis - marketscreener.com

Mar 30, 2026
pulisher
Mar 30, 2026

Quantum BioPharma Taps Allucent for Phase 2 Trial of Novel MS Drug Lucid-MS - tipranks.com

Mar 30, 2026
pulisher
Mar 30, 2026

Quantum BioPharma And Allucent Enter Binding Letter Of Intent For Phase 2 Clinical Trial In Multiple Sclerosis - marketscreener.com

Mar 30, 2026
pulisher
Mar 30, 2026

Quantum BioPharma partners with Allucent for MS drug trial - Investing.com

Mar 30, 2026
pulisher
Mar 30, 2026

Quantum BioPharma Partners with Allucent to Advance Phase 2 Clinical Trial of Lucid-MS for Multiple Sclerosis Treatment - Quiver Quantitative

Mar 30, 2026
pulisher
Mar 30, 2026

Quantum BioPharma (QNTM) lines up Allucent for Lucid-MS Phase 2 trial - Stock Titan

Mar 30, 2026
pulisher
Mar 30, 2026

Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis - GlobeNewswire

Mar 30, 2026
pulisher
Mar 30, 2026

Portfolio Recap: Will Quantum BioPharma Ltd stock benefit from M A2026 Breakouts & Breakdowns & Safe Capital Growth Plans - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 30, 2026

Quantum BioPharma Raises C$3.75 Million and Converts Debt in Capital Restructuring Push - TipRanks

Mar 30, 2026
pulisher
Mar 29, 2026

Quantum BioPharma Ltd.: Fundamental Analysis and Financial Ratings | 0K91 | CA74764Y2050 - marketscreener.com

Mar 29, 2026

Quantum Biopharma Ltd Stock (QNTM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$54.26
price up icon 2.69%
$48.70
price down icon 0.25%
$99.47
price up icon 1.08%
$152.54
price up icon 3.76%
$146.74
price down icon 4.34%
ONC ONC
$319.94
price up icon 3.21%
Cap:     |  Volume (24h):